Digital health tech is moving beyond the consumer market. Research from Frost & Sullivan shows that the healthcare wearables device market could more than triple to $18.9 billion in 2020 from $5.1 billion in 2015. The healthcare and pharmaceutical industries are fully embracing wearables to monitor patients between visits, improve patient adherence to medications and accelerate clinical drug trials.
Wearables can give healthcare professionals insights into patient behavior and disease progression through a steady flow of electronic data transmitted by the devices. Medical wearables also enable clinicians and pharmaceutical companies conducting drug trials to collect more patient-generated health data to guide treatment for individual patients and contribute to ongoing population health analytics research initiatives.
In a new survey on how digital health devices and data impact clinical trials, digital health technology vendor Validic reported:
Image pulled from original article.
Recommendations on how we should use AI, genomics and medtech in the NHS – click here for 98 pages to guide us to the future. ‘The greatest challenge is the culture shift in learning and innovation, with a willingness to embrace technology for system-wide improvement. An ambitious drive “towards the NHS becoming the world’s largest learning organisation”’.
You're the expert! Write for The Engine or share your articles, papers and researchAdd your content
Add your content
Sign up for Ignition, our regular, ideas-packed newsletter